Tarsus Pharmaceuticals (TARS) Q4 2024 Earnings

Nov 13Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.37
-1.12
-0.86
-0.61

Details

Expected EPS
-0.939817
Actual EPS
-0.61
Surprise EPS
0.33
Surprise Percent
+35.09%

Description

⁨Tarsus Pharmaceuticals⁩ (⁦TARS⁩) has reported earnings of ⁦-0.61⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts